If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Form 8.3 - DX LN

4 Jan 2024 15:30

RNS Number : 6755Y
Syquant Capital
04 January 2024

Table

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings are being disclosed:

SYQUANT CAPITAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

DX Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

January 3, 2024

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

1p ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

11,303,000

1.86%

(2) Derivatives (other than options):

47,000

0.00%

(3) Options and agreements to purchase/sell:

TOTAL:

11,350,000

1.87%

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other executive options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

1p ordinary

Purchase

994,049

47 GBp

(b) Derivatives transactions (other than options)

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

1p ordinary

CFD

increasing a long position

5,951

47 GBp

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercising

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

N/A

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

N/A

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

January 4, 2024

Contact name:

Laurent Boscherel

Telephone number:

+33 1 42 56 56 27

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETUSVRRSBUARAR
Date   Source Headline
18th Sep 20174:40 pmRNSSecond Price Monitoring Extn
18th Sep 20174:35 pmRNSPrice Monitoring Extension
15th Sep 20177:00 amRNSRe full year accounts
1st Sep 20178:47 amRNSHolding(s) in Company
31st Aug 20174:40 pmRNSSecond Price Monitoring Extn
31st Aug 20174:35 pmRNSPrice Monitoring Extension
23rd Aug 20175:46 pmRNSHolding(s) in Company
21st Aug 20177:30 amRNSRestoration - DX (Group) Plc
21st Aug 20177:00 amRNSResumption of trading in DX shares
14th Aug 20177:00 amRNSTermination of Discussions with John Menzies plc
14th Aug 20177:00 amRNSTermination of discussions with DX (Group) plc
14th Jul 20179:06 amRNSResponse to DX (Group) plc announcement
14th Jul 20177:00 amRNSTrading Update
7th Jul 20173:22 pmRNSResponse to DX (Group) plc announcement
7th Jul 20177:00 amRNSRe: City of London Police Investigation
30th Jun 20177:00 amRNSBoard Appointment
9th Jun 20178:00 amRNSResponse to DX (Group) plc announcement
9th Jun 20177:00 amRNSInvestigation by the City of London Police
5th Jun 20177:00 amRNSUpdate on Proposed Combination
5th Jun 20177:00 amRNSRe: John Menzies' Distribution Division - update
26th May 20171:27 pmRNSHolding(s) in Company
24th May 20175:55 pmRNSHolding(s) in Company
12th May 20177:00 amRNSAGM Trading Update
7th Apr 20171:45 pmRNSWithdrawal of Requisition of General Meeting
31st Mar 20177:30 amRNSSuspension - DX (Group) plc
31st Mar 20177:00 amRNSInterim Results
31st Mar 20177:00 amRNSRe: John Menzies' Distribution Division
31st Mar 20177:00 amRNSPotential combination of DX & Menzies Distribution
29th Mar 20177:00 amRNSMajor New Contract Win
21st Mar 20177:00 amRNSResponse to Requisition Notice
20th Mar 201711:17 amRNSRequisition of General Meeting
6th Mar 20177:00 amRNSChange of Registered Office
1st Mar 20177:00 amRNSRe: Proposed West Midlands Hub
9th Feb 20174:47 pmRNSHolding(s) in Company
8th Feb 201710:41 amRNSHolding(s) in Company
7th Feb 20177:00 amRNSTrading update
23rd Dec 201611:10 amRNSHolding(s) in Company
6th Dec 201610:59 amRNSResult of AGM
1st Dec 20167:00 amRNSReappointment to the Board
22nd Nov 20167:00 amRNSHMPO Contract and Trading Update
21st Nov 20167:00 amRNSRe: Annual General Meeting
15th Nov 20167:00 amRNSPosting of Accounts & Notice of AGM
4th Nov 20164:40 pmRNSSecond Price Monitoring Extn
4th Nov 20164:35 pmRNSPrice Monitoring Extension
21st Oct 20167:11 amRNSRe CMA Review - Investigation Now Closed
7th Oct 20163:10 pmRNSHolding(s) in Company
26th Sep 20166:22 pmRNSHolding(s) in Company
26th Sep 20164:40 pmRNSSecond Price Monitoring Extn
26th Sep 20164:35 pmRNSPrice Monitoring Extension
21st Sep 20167:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.